GradedCalls Analysts
Loading the ledger…
Public news sources, graded against Yahoo Finance adjusted closes (adjusted for splits and dividends) through 16 Oct 2026. Not investment advice.
GradedCallsGradedCallsGradedCalls Analysts
Loading the ledger…
NYSE · Healthcare
Eli Lilly · Pharmaceuticals. Historical grades below use the calls in this ledger. The list is each analyst’s latest recommendation. The bar under it is the direction for grading, not a live street tally.
Direction for grading, from the latest active call of each analyst. Strong Buy, Buy, Overweight, and Outperform count as Buy. Hold, Neutral, and Equal-Weight count as Hold. Underperform, Underweight, and Sell count as Sell. The recommendation on the call — Target raise, Upgrade to Buy, Reiterate Overweight — is a separate label.
Overall factor · 90D
16.1/100Average of active call grades
GC score2/10GC 1→GC 10
GC 1–4. Under 40 is WEAK on the GC Scale.
The overall factor is the average of the 0–100 grades on active calls at this horizon. A call superseded by a later note on the same ticker within 90 days stays visible and does not enter this average, the GC score, or the hit rate. How this is computed
Active graded
| Analyst | Firm | N | Hit | Overall factor/100 · GC 1–10 |
|---|---|---|---|---|
| Courtney Breen | Bernstein | 1 | 0% | 44.5/1005/10 |
| Jason Gerberry | BofA | 1 | 0% | 17.5/1002/10 |
| Michael Yee | UBS | 1 | 0% | 2.5/100 |
These calls count toward the overall factor once the horizon has a price. An open window is listed and is not in the average yet.
| Date | Analyst | Recommendation | Directionfor grading | Target | Then | After | Return | Grade |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 Supersedes Supersedes prior call on Aug 6, 2026 (within 90 days). Prior call | Carter GouldCantor | Target raise Desk rating stays Overweight | Buy | — | — | |||
| Oct 7, 2026 |
4
In this factor
Superseded
3
Visible, not scored
Hit rate
0%
Active calls only
If followed
+0.6%
Active directional calls
Active calls on LLY were a full hit 0% of the time. Hit rate is not the rank.
| Geoff Meacham | Citi | 1 | 0% | 0/100—/10 EXIT LIQUIDITY |
| Terence FlynnMorgan Stanley |
| Target raise Desk rating stays Overweight |
| Buy |
| — |
| — |
| Sep 22, 2026 | Steve ScalaTD Cowen | Reiterate Buy Desk rating stays Buy | Buy | — | — |
| Sep 18, 2026 Supersedes Supersedes prior call on Jul 13, 2026 (within 90 days). Prior call | Seamus FernandezGuggenheim | Target raise Desk rating stays Buy | Buy | — | — |
| Aug 7, 2026 Supersedes Supersedes prior call on Jul 8, 2026 (within 90 days). Prior call | Robyn KarnauskasTruist | Target raise Desk rating stays Buy | Buy | — | — |
| Aug 6, 2026 | Mohit BansalWells Fargo | Target raise Desk rating stays Overweight | Buy | — | — |
| Jul 15, 2026 | Geoff MeachamCiti | Target raise Desk rating stays Buy | Buy | $1,166.51 | +1.0% | Miss |
| Jul 14, 2026 | Courtney BreenBernstein | Target raise Desk rating stays Outperform | Buy | $1,182.62 | +2.8% | Near |
| Jul 13, 2026 | Michael YeeUBS | Target raise Desk rating stays Buy | Buy | $1,179.27 | -0.1% | Miss |
| Jul 10, 2026 | Jason GerberryBofA | Target raise Desk rating stays Buy | Buy | $1,169.60 | -1.5% | Miss |